4.7 Letter

Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 Year

Journal

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 317, Issue 10, Pages 1074-1077

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jama.2016.20644

Keywords

-

Funding

  1. European Union's Innovative Medicines Initiative, as part of the EBOVAC1 consortium [115854]
  2. European Union
  3. European Federation of Pharmaceutical Industries and Associations
  4. National Institute for Health Research Oxford Biomedical Research Centre

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available